Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
We figured out the best pharmaceutical companies to work for in California using data on salaries, company financial health, and employee diversity. You can also search for the best pharmaceutical companies to work for in any other state or city.

Zippia score 4.7
Quidel was founded in 1979 and eventually launched its first product in 1984. It is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system.
Zippia score 4.7
Prometheus Laboratories Inc. provide diagnostics which enable unique health solutions. Considered as a leader of precision healthcare in gastroenterolgy, it develops and brings to the market diagnostic tests that help physicians provide the highest level of patient care. Since 2011, it has been a part of Nestle Health Science, aiming to change the way people approach and manage their health.
Zippia score 4.6
Tandem Diabetes Care, Inc. develops medical devices for the treatment of diabetes. It offers diabetic insulin pumps for adults and children to diabetes needs, including keeping blood glucose levels within target ranges. The company focuses on insulin infusion therapy. Tandem Diabetes Care, Inc. was incorporated in 2006 and is based in San Diego, California.
Zippia score 4.6
Zippia score 4.5
Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company's current commercial efforts are focused on five products. UCERIS (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis and ZEGERID (omeprazole/sodium bicarbonate) for the treatment of certain upper gastrointestinal disorders are promoted to gastroenterologists.
Zippia score 4.5
Therapeutics, Inc. is a drug development company dedicated to innovation. We focus on dermatology-related areas of medicine and provide unwavering service and commitment to moving products from concept to the bench top, to proof-of-concept and then, if appropriate, through clinical development with regulatory review and approval.
Zippia score 4.5
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Ligand business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. Ligand partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate Ligand revenue.
Zippia score 4.5
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.
Zippia score 4.4
mission of Imprimis Pharmaceuticals is to improve patient health and their quality of life by working with innovative compounding pharmacists and drug developers to commercialize compounded drug formulations. We are also focused on leveraging Accudel, a patented topical drug delivery platform, that enables highly targeted site specific treatment. Why are we focused on topical drug delivery? Because delivering medicines locally to a specific site in the body instead of swallowing a pill, for example, allows for a reduction in problematic side effects often associated with systemic delivery. We believe our focus on compounded drug formulations and topical drug delivery improves patient health and quality of life.
Zippia score 4.3
HUYA Bioscience started in 2004 with a vision. I wanted to identify and add value to the wealth of therapeutic opportunities from Chinese institutes and universities. In the few intervening years, HUYA has grown to be the leader in globalizing China's pharmaceutical innovation. Meeting the challenge of tomorrow's unmet medical needs requires utilizing the talents of Chinese researchers and helping to move their discoveries forward. The HUYA team both in San Diego and their eight China offices is committed to building relationships that enable candidate compounds to be more accessible internationally. With diverse approaches including in-licensing, alliances with large pharmaceutical companies, co-development and research funding, HUYA is poised to bring China's health care discoveries to the world.
Zippia score 4.3
Suneva Medical, Inc. is a privately held medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets. It provides a novel and differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets. The company's flagship brand, Bellafill is the only dermal filler on the market with five-year safety and efficacy data, and the only dermal filler approved for the correction of facial acne scars. The Company was formed in April 2009 and is backed by HealthCare Royalty Partners, a global healthcare investment firm with $1.5 billion in capital under management. HC Royalty's investment strategy is to make long-term investments in unique and promising healthcare products and companies. The firm has a proven track record of success. The Suneva Medical product portfolio focuses on compelling, differentiated products that deliver high patient satisfaction and represent a significant business opportunity to its practice partners.
Zippia score 4.2
Turning Point Therapeutics, Inc. is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. We are focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.
Zippia score 4.1
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of unique host-directed anti-viral.The company is committed to developing safe and effective immuno-biologic therapies to treat the most vulnerable patients. Its founders were ingenious virologists and molecular biologists who realized that targeting a virus is difficult due to the virus's ability to mutate and avoid the treatment. This ability to mutate also enables the virus to evade vaccines. So instead of trying to hit a moving target, they developed an innovative new approach to fight respiratory viruses: they targeted the host instead of the virus.
Zippia score 4.0
Somaxon Pharmaceuticals is a growing specialty pharmaceutical company dedicated to commercializing proprietary branded prescription therapeutics to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction. The company currently is focusing on in-licensing, developing and marketing proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxon currently is promoting Silenor , the first and only nonscheduled prescription medication approved for the treatment of sleep maintenance insomnia. Silenor is now available for prescription in the United States.
Zippia score 4.0
Pharmatek provides dosage form development and clinical-scale cGMP manufacturing of oral, injectable and topical products for more than 100 customers globally. At its San Diego facility, Pharmatek offers a fully integrated drug development platform, with discovery formulation screening for lead selection and optimization, comprehensive formulation development and analytical services, and finished dose form manufacturing for clinical supply.
Zippia score 3.9
VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of medicines for the treatment of cancer, and respiratory and autoimmune diseases. The company focuses on the development of small molecule product candidates targeting toll-like receptor 8 (TLR8) agonists and antagonists. Its product pipeline comprises VTX-2337, a small molecule TLR8 agonist that stimulates myeloid dendritic cells and monocytes, and enhances natural killer cell responses for the treatment of solid tumors, ovarian and breast cancers, and NHL and SCHN; VTX-1463, a stand alone agent for the treatment of seasonal and perennial allergies; TLR8 antagonists for the treatment of autoimmune diseases; and multiple compounds that are treated as vaccine adjuvants. The company has a strategic agreement/collaboration with Celgene Corporation. VentiRx Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Seattle, Washington with operations in San Diego.
Zippia score 3.9
Crinetics Pharmaceuticals Inc. discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. All Their programs are derived from internal discovery efforts and use objective hormonal biomarker endpoints for preclinical and clinical studies to reduce both the risk and cost to achieve meaningful clinical data. Crinetics is seeking motivated partners to help advance Their programs to become commercially successful products.
Zippia score 3.8
Tanvex Biopharma Usa, Inc. is primarily engaged in commercial physical and biological research and development on a contract or fee basis.
Zippia score 3.7
ARS Pharmaceuticals is a stealth pharmaceutical company that developed a novel intranasal epinephrine spray with a unique absorption technology that could be easy-to-use, convenient, and more reliable for patients and loved ones at risk of severe allergic reactions to food, medications and insect bites that could lead to life-threatening anaphylaxis.
Zippia score 3.6
Zippia score 4.9
Building families and helping people live better lives. • Guidelines: https://t.co/5aDAoDV3H2
Zippia score 4.9
5764914 Novartis International AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland.
Zippia score 4.7
Lexicon Pharmaceuticals, Inc. (formerly Lexicon Genetic) a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and ophthalmology. The company's drug candidates include LX1031, which has completed Phase II clinical trials for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 diabetes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; collaboration agreement with Taconic Farms, Inc.; and an alliance with Nuevolution A/S, which provides access to Nuevolution's Chemetics platform chemistry technology.
Zippia score 4.7
Johnson & Johnson engages in the research and development, manufacture, and sale of a range of products in the healthcare field. The company operates through three business segments, including Consumer; Pharmaceutical and Medical Devices; and Diagnostics. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products. The Baby Care franchise includes the JOHNSON'S Baby line of products. Major brands in the Skin Care franchise include the AVEENO; CLEAN & CLEAR; JOHNSON'S Adult; NEUTROGENA; RoC; LUBRIDERM; Beijing Dabao Cosmetics Co., Ltd.; and Vendome product lines. The Oral Care franchise includes the LISTERINE and REACH oral care lines of products. Major brands in the Women's Health franchise are the CAREFREE Pantiliners and STAYFREE sanitary protection products. The nutritional and over-the-counter lines include SPLENDA, No Calorie Sweetener; the family of TYLENOL acetaminophen products; SUDAFED cold, flu and allergy products; ZYRTEC allergy products; MOTRIN IB ibuprofen products; and PEPCID AC Acid Controller from Johnson & Johnson Merck Consumer Pharmaceuticals Co. These products are marketed principally to the general public and sold both to wholesalers and directly to independent and chain retail outlets throughout the world. Pharmaceutical The Pharmaceutical segment includes products in the following therapeutic areas: anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use by the general public. Key products in the Pharmaceutical segment include: REMICADE (infliximab), a biologic approved for the treatment of Crohn's disease, ankylosing spondylitis, psoriasis, psoriatic arthritis, ulcerative colitis, and use in the treatment of rheumatoid arthritis; TOPAMAX (topiramate), approved for adjunctive and monotherapy use in epilepsy, as well as for the prophylactic treatment of migraines; PROCRIT (Epoetin alfa, sold outside the U.S. as EPREX), a biotechnology-derived product that stimulates red blood cell production; RISPERDAL oral (risperidone), a medication that treats the symptoms of schizophrenia, bipolar mania and irritability associated with autistic behavior in indicated patients, RISPERDAL CONSTA (risperidone), a long-acting injectable, and INVEGA (paliperdone) Extended-Release tablets, for the treatment of schizophrenia; LEVAQUIN (levofloxacin) and FLOXIN (ofloxacin), both in the anti-infective field; CONCERTA (methylphenidate HCl), a product for the treatment of attention deficit hyperactivity disorder; ACIPHEX/PARIET, a proton pump inhibitor co-marketed with Eisai Inc.; and DURAGESIC/Fentanyl Transdermal (fentanyl transdermal system, sold outside the U.S. as DUROGESIC), a treatment for chronic pain that offers a novel delivery system. Medical Devices and Diagnostics The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics. These products include Cordis' circulatory disease management products; DePuy's orthopaedic joint reconstruction, spinal care and sports medicine products; Ethicon's surgical care and women's health products; Ethicon Endo-Surgery's minimally invasive surgical products; LifeScan's blood glucose monitoring and insulin delivery products; Ortho-Clinical Diagnostics' professional diagnostic products and Vistakon's disposable contact lenses.
Zippia score 4.7
Pacira Pharmaceuticals Inc. operates as a pharmaceutical company which engages in the development and manufacturing of injectable pharmaceutical products. Pacira Pharmaceuticals Inc. was formerly known as DepoTech Corp. was formerly as SkyePharma Inc. and changed its name to Pacira Pharmaceuticals Inc. in June, 2007. The company was founded in 1989 and is based in San Diego, California. Pacira Pharmaceuticals Inc. operates as a subsidiary of Pacira, Inc.
Zippia score 4.7
Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical treatments for metabolic and cardiovascular disease, central nervous system disease, respiratory and immunology, oncology, and general medicine areas. It offers products for the treatment of type II diabetes, hypertension, insomnia, Alzheimer s-type dementia, hyperuricemia and gout, peptic ulcer, acid reflux, multiple myeloma, prostate and breast cancer, endometriosis, cancer, malignant lymphoma, and major depressive disorder diseases. The company was founded in 1998 and is based in Deerfield, Illinois. It has business and sales operations in Europe, the Russian Federation, CIS, Japan, North America, Latin America, Asia, and internationally. Takeda Pharmaceuticals U.S.A., Inc. operates as a subsidiary of Takeda Pharmaceutical Company Limited.
Zippia score 4.6
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases. The company is driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. Merck delivers vaccines, medications, and consumer and animal health products that can help millions around the world. Merck was founded in 1891 and is headquartered in Kenilworth, NJ.
Zippia score 4.6
Eli Lilly and Company is known for their high-quality medicines which are being distributed to 125 countries. Founded in 1876 by Col. Eli Lilly, this global pharmaceutical company remains committed to his vision through every aspect of their business and the people they serve, starting with those who take their medicines, and extending to health care professionals, employees and the communities in which they live. They currently have up to $1 billion in revenue and around 10,000 employees.
Zippia score 4.6
Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.
Zippia score 4.5
Headquartered in Louisville, Kentucky, PharMerica is one of the largest and fastest growing institutional pharmacy services companies in America. We are a premier pharmacy services provider dedicated to providing innovative solutions for customers and patients. At PharMerica, you can choose your career path – hospital pharmacy, long term care pharmacy, corporate and non-clinical opportunities. Who Works for PharMerica? We employ some of the industry’s best and brightest innovators and clinicians. PharMerica employs dedicated employees and pharmacy professionals for its long-term care pharmacies nationwide. We offer our staff the opportunity to learn the business and cross train in other areas to provide a catalyst for their career growth within PharMerica. We also recruit our next generation of leaders by hiring new graduates from some of the nation’s top pharmacy and business schools.
Zippia score 4.5
A fully integrated, life sciences commercial services company -designed to solve pricing, access, reimbursement, adherence and product delivery challenges
Zippia score 4.5
Today's highly innovative biotech and specialty pharma companies are doing incredible things. It's amazing science, and we've positioned ourselves right in the middle of the action, targeting the therapeutic areas where these pioneers are doing the most exciting work. Their unparalleled experience in analgesia spans more than 850 trials and includes every NSAID painkiller sold today.
Zippia score 4.4
Husa Liquidating Corporation, formerly HearUSA, Inc., provides a range of hearing aids, with emphasis on digital technology along with assessment and evaluation of hearing. The Company operates in three segments: the Company-owned centers, the network ...
Zippia score 4.4
Covance Inc. is a global contract research organization recognized for being the world's most comprehensive drug development company. It has a team of professionals that are dedicated to advancing healthcare and delivering fast and innovative medical solutions to patients and healthcare providers. The company also offers laboratory testing services to the chemical, agrochemical, and food industries. It is also a market leader in central laboratory, toxicology, and discovery services.
Zippia score 4.4
A bracket is a tall punctuation mark commonly used in matched pairs within text, to set apart or interject other text. The members of the matched pair may be described as opening and closing brackets.
Zippia score 4.4
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, a FXR modulating agent that treats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases. Intercept Pharmaceuticals, Inc. was founded in 2002 and is based in New York, New York.
Zippia score 4.4
Catalent Pharma Solutions, Inc. provides drug delivery technologies and outsourced development, manufacturing, and packaging services to the pharmaceutical, biotechnology, and consumer health industry worldwide. It operates in four segments: Development and Clinical Services, Oral Technologies, Sterile Technologies, and Packaging Services. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management for drugs and biologics in clinical trials. It also offers analytical chemical and cell-based testing and scientific services, respiratory products formulation and manufacturing, regulatory consulting, and biologics proprietary expression technology, and product development. The Oral Technologies segment provides formulation, development, and manufacturing services for the oral dose forms. Its oral drug delivery technologies include proprietary delivery technologies for drugs and consumer health products. This segment also offers formulation, development, and manufacturing services for conventional oral dose forms, including controlled release formulations, as well as immediate release tablets and capsules. The Sterile Technologies segment provides proprietary and traditional dose forms for separate routes of administration. It offers formulation and development for injectable drugs; and fills drugs or biologics into vials, pre-filled syringes, bags, and other sterile delivery formats. This segment's blow-fill-seal technology provides integrated dose form creation and filling of sterile liquids in a single process for respiratory, ophthalmic, and other routes of administration. The Packaging Services segment offers packaging services for pharmaceuticals, biologics, consumer health, and veterinary products, which include packaging drugs in blisters, bottles, pouches, and unit doses; and printed components, such as creating package inserts or folding cartons. The company is based in Somerset, New Jersey.
Zippia score 4.4
Eurofins is an international group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments.
Zippia score 4.3
Charles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services
Zippia score 4.3
Sterigenics Holdings, Inc., through its subsidiary, provides contract sterilization solutions to the medical device and pharmaceutical industries. The company is based in the United States. Sterigenics Holdings, Inc. operates as a subsidiary of STHI Holding Corp.
| Rank | Company | Zippia score |
|---|---|---|
| 1 | Quidel | |
| 2 | Prometheus | |
| 3 | Tandem Diabetes Care | |
| 4 | Optimer Pharmaceuticals | |
| 5 | Santarus | |
| 6 | Therapeutics | |
| 7 | Ligand Pharmaceuticals | |
| 8 | Cadence Pharmaceuticals | |
| 9 | Imprimis Pharmaceuticals | |
| 10 | HUYABIO International | |
| 11 | Suneva Medical | |
| 12 | Turning Point Therapeutics | |
| 13 | AnsunBiopharma | |
| 14 | Somaxon Pharmaceuticals | |
| 15 | Pharmatek Laboratries | |
| 16 | VentiRx Pharmaceuticals | |
| 17 | Crinetics Pharmaceuticals | |
| 18 | Tanvex Biopharma Usa, Inc | |
| 19 | ARS Pharmaceuticals | |
| 20 | American Life Science Pharmaceuticals, Inc. |